The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Chronic Kidney Disease (CKD)-Global Market Insights and Sales Trends 2024
Synopsis
The global Chronic Kidney Disease (CKD) market size is expected to reach US$ 111810 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Chronic Kidney Disease (CKD) in various end use industries. The expanding demands from the Hospitals and Specialty Clinics, are propelling Chronic Kidney Disease (CKD) market. ACE Inhibitors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Calcium Channel Blockers segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Chronic Kidney Disease (CKD) market, driven by demand from China, the second largest economy with some signs of stabilising, the Chronic Kidney Disease (CKD) market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Chronic Kidney Disease (CKD), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Chronic Kidney Disease (CKD) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Chronic Kidney Disease (CKD) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Chronic Kidney Disease (CKD) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Chronic Kidney Disease (CKD) covered in this report include AbbVie, Allergan, Amgen, AstraZeneca, Roche, FibroGen, GlaxoSmithKline, Johnson & Johnson and Keryx, etc.
The global Chronic Kidney Disease (CKD) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AbbVie
Allergan
Amgen
AstraZeneca
Roche
FibroGen
GlaxoSmithKline
Johnson & Johnson
Keryx
Kissei
Pfizer
Sanofi
Teva
Global Chronic Kidney Disease (CKD) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Chronic Kidney Disease (CKD) market, Segment by Type:
ACE Inhibitors
Calcium Channel Blockers
Beta Blockers
Others
Global Chronic Kidney Disease (CKD) market, by Application
Hospitals
Specialty Clinics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Chronic Kidney Disease (CKD) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Chronic Kidney Disease (CKD) market size is expected to reach US$ 111810 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Chronic Kidney Disease (CKD) in various end use industries. The expanding demands from the Hospitals and Specialty Clinics, are propelling Chronic Kidney Disease (CKD) market. ACE Inhibitors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Calcium Channel Blockers segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Chronic Kidney Disease (CKD) market, driven by demand from China, the second largest economy with some signs of stabilising, the Chronic Kidney Disease (CKD) market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Chronic Kidney Disease (CKD), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Chronic Kidney Disease (CKD) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Chronic Kidney Disease (CKD) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Chronic Kidney Disease (CKD) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Chronic Kidney Disease (CKD) covered in this report include AbbVie, Allergan, Amgen, AstraZeneca, Roche, FibroGen, GlaxoSmithKline, Johnson & Johnson and Keryx, etc.
The global Chronic Kidney Disease (CKD) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AbbVie
Allergan
Amgen
AstraZeneca
Roche
FibroGen
GlaxoSmithKline
Johnson & Johnson
Keryx
Kissei
Pfizer
Sanofi
Teva
Global Chronic Kidney Disease (CKD) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Chronic Kidney Disease (CKD) market, Segment by Type:
ACE Inhibitors
Calcium Channel Blockers
Beta Blockers
Others
Global Chronic Kidney Disease (CKD) market, by Application
Hospitals
Specialty Clinics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Chronic Kidney Disease (CKD) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Chronic Kidney Disease (CKD)
1.1 Chronic Kidney Disease (CKD) Market Overview
1.1.1 Chronic Kidney Disease (CKD) Product Scope
1.1.2 Chronic Kidney Disease (CKD) Market Status and Outlook
1.2 Global Chronic Kidney Disease (CKD) Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Chronic Kidney Disease (CKD) Market Size by Region (2018-2029)
1.4 Global Chronic Kidney Disease (CKD) Historic Market Size by Region (2018-2023)
1.5 Global Chronic Kidney Disease (CKD) Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Chronic Kidney Disease (CKD) Market Size (2018-2029)
1.6.1 North America Chronic Kidney Disease (CKD) Market Size (2018-2029)
1.6.2 Europe Chronic Kidney Disease (CKD) Market Size (2018-2029)
1.6.3 Asia-Pacific Chronic Kidney Disease (CKD) Market Size (2018-2029)
1.6.4 Latin America Chronic Kidney Disease (CKD) Market Size (2018-2029)
1.6.5 Middle East & Africa Chronic Kidney Disease (CKD) Market Size (2018-2029)
2 Chronic Kidney Disease (CKD) Market by Type
2.1 Introduction
2.1.1 ACE Inhibitors
2.1.2 Calcium Channel Blockers
2.1.3 Beta Blockers
2.1.4 Others
2.2 Global Chronic Kidney Disease (CKD) Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Chronic Kidney Disease (CKD) Historic Market Size by Type (2018-2023)
2.2.2 Global Chronic Kidney Disease (CKD) Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Chronic Kidney Disease (CKD) Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Chronic Kidney Disease (CKD) Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Chronic Kidney Disease (CKD) Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Chronic Kidney Disease (CKD) Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Chronic Kidney Disease (CKD) Revenue Breakdown by Type (2018-2029)
3 Chronic Kidney Disease (CKD) Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Specialty Clinics
3.2 Global Chronic Kidney Disease (CKD) Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Chronic Kidney Disease (CKD) Historic Market Size by Application (2018-2023)
3.2.2 Global Chronic Kidney Disease (CKD) Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Chronic Kidney Disease (CKD) Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Chronic Kidney Disease (CKD) Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Chronic Kidney Disease (CKD) Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Chronic Kidney Disease (CKD) Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Chronic Kidney Disease (CKD) Revenue Breakdown by Application (2018-2029)
4 Chronic Kidney Disease (CKD) Competition Analysis by Players
4.1 Global Chronic Kidney Disease (CKD) Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Chronic Kidney Disease (CKD) as of 2022)
4.3 Date of Key Players Enter into Chronic Kidney Disease (CKD) Market
4.4 Global Top Players Chronic Kidney Disease (CKD) Headquarters and Area Served
4.5 Key Players Chronic Kidney Disease (CKD) Product Solution and Service
4.6 Competitive Status
4.6.1 Chronic Kidney Disease (CKD) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 AbbVie
5.1.1 AbbVie Profile
5.1.2 AbbVie Main Business
5.1.3 AbbVie Chronic Kidney Disease (CKD) Products, Services and Solutions
5.1.4 AbbVie Chronic Kidney Disease (CKD) Revenue (US$ Million) & (2018-2023)
5.1.5 AbbVie Recent Developments
5.2 Allergan
5.2.1 Allergan Profile
5.2.2 Allergan Main Business
5.2.3 Allergan Chronic Kidney Disease (CKD) Products, Services and Solutions
5.2.4 Allergan Chronic Kidney Disease (CKD) Revenue (US$ Million) & (2018-2023)
5.2.5 Allergan Recent Developments
5.3 Amgen
5.3.1 Amgen Profile
5.3.2 Amgen Main Business
5.3.3 Amgen Chronic Kidney Disease (CKD) Products, Services and Solutions
5.3.4 Amgen Chronic Kidney Disease (CKD) Revenue (US$ Million) & (2018-2023)
5.3.5 AstraZeneca Recent Developments
5.4 AstraZeneca
5.4.1 AstraZeneca Profile
5.4.2 AstraZeneca Main Business
5.4.3 AstraZeneca Chronic Kidney Disease (CKD) Products, Services and Solutions
5.4.4 AstraZeneca Chronic Kidney Disease (CKD) Revenue (US$ Million) & (2018-2023)
5.4.5 AstraZeneca Recent Developments
5.5 Roche
5.5.1 Roche Profile
5.5.2 Roche Main Business
5.5.3 Roche Chronic Kidney Disease (CKD) Products, Services and Solutions
5.5.4 Roche Chronic Kidney Disease (CKD) Revenue (US$ Million) & (2018-2023)
5.5.5 Roche Recent Developments
5.6 FibroGen
5.6.1 FibroGen Profile
5.6.2 FibroGen Main Business
5.6.3 FibroGen Chronic Kidney Disease (CKD) Products, Services and Solutions
5.6.4 FibroGen Chronic Kidney Disease (CKD) Revenue (US$ Million) & (2018-2023)
5.6.5 FibroGen Recent Developments
5.7 GlaxoSmithKline
5.7.1 GlaxoSmithKline Profile
5.7.2 GlaxoSmithKline Main Business
5.7.3 GlaxoSmithKline Chronic Kidney Disease (CKD) Products, Services and Solutions
5.7.4 GlaxoSmithKline Chronic Kidney Disease (CKD) Revenue (US$ Million) & (2018-2023)
5.7.5 GlaxoSmithKline Recent Developments
5.8 Johnson & Johnson
5.8.1 Johnson & Johnson Profile
5.8.2 Johnson & Johnson Main Business
5.8.3 Johnson & Johnson Chronic Kidney Disease (CKD) Products, Services and Solutions
5.8.4 Johnson & Johnson Chronic Kidney Disease (CKD) Revenue (US$ Million) & (2018-2023)
5.8.5 Johnson & Johnson Recent Developments
5.9 Keryx
5.9.1 Keryx Profile
5.9.2 Keryx Main Business
5.9.3 Keryx Chronic Kidney Disease (CKD) Products, Services and Solutions
5.9.4 Keryx Chronic Kidney Disease (CKD) Revenue (US$ Million) & (2018-2023)
5.9.5 Keryx Recent Developments
5.10 Kissei
5.10.1 Kissei Profile
5.10.2 Kissei Main Business
5.10.3 Kissei Chronic Kidney Disease (CKD) Products, Services and Solutions
5.10.4 Kissei Chronic Kidney Disease (CKD) Revenue (US$ Million) & (2018-2023)
5.10.5 Kissei Recent Developments
5.11 Pfizer
5.11.1 Pfizer Profile
5.11.2 Pfizer Main Business
5.11.3 Pfizer Chronic Kidney Disease (CKD) Products, Services and Solutions
5.11.4 Pfizer Chronic Kidney Disease (CKD) Revenue (US$ Million) & (2018-2023)
5.11.5 Pfizer Recent Developments
5.12 Sanofi
5.12.1 Sanofi Profile
5.12.2 Sanofi Main Business
5.12.3 Sanofi Chronic Kidney Disease (CKD) Products, Services and Solutions
5.12.4 Sanofi Chronic Kidney Disease (CKD) Revenue (US$ Million) & (2018-2023)
5.12.5 Sanofi Recent Developments
5.13 Teva
5.13.1 Teva Profile
5.13.2 Teva Main Business
5.13.3 Teva Chronic Kidney Disease (CKD) Products, Services and Solutions
5.13.4 Teva Chronic Kidney Disease (CKD) Revenue (US$ Million) & (2018-2023)
5.13.5 Teva Recent Developments
6 North America
6.1 North America Chronic Kidney Disease (CKD) Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Chronic Kidney Disease (CKD) Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Chronic Kidney Disease (CKD) Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Chronic Kidney Disease (CKD) Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Chronic Kidney Disease (CKD) Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Chronic Kidney Disease (CKD) Market Dynamics
11.1 Chronic Kidney Disease (CKD) Industry Trends
11.2 Chronic Kidney Disease (CKD) Market Drivers
11.3 Chronic Kidney Disease (CKD) Market Challenges
11.4 Chronic Kidney Disease (CKD) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
